Parvovirus B19 serology in early inflammatory polyarthritis - Experience from a tertiary care teaching hospital in South India

D. Danda, Harris V K Naina, Mary Abraham, Ashish Jacob Mathew, Ashish K. Badika, John Mathew

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8%) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.

Original languageEnglish (US)
JournalJournal of the Indian Medical Association
Volume108
Issue number10
StatePublished - Oct 2010

Fingerprint

Parvovirus
Serology
Tertiary Healthcare
Teaching Hospitals
Arthritis
India
Joint Diseases
Immunoglobulin M
Antibodies
Preexisting Condition Coverage
Arthralgia
Rheumatology
Exanthema
Fever
Outpatients
Viruses

Keywords

  • Early inflammatory arthritis
  • Parvovirus B19

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Parvovirus B19 serology in early inflammatory polyarthritis - Experience from a tertiary care teaching hospital in South India. / Danda, D.; Naina, Harris V K; Abraham, Mary; Mathew, Ashish Jacob; Badika, Ashish K.; Mathew, John.

In: Journal of the Indian Medical Association, Vol. 108, No. 10, 10.2010.

Research output: Contribution to journalArticle

Danda, D. ; Naina, Harris V K ; Abraham, Mary ; Mathew, Ashish Jacob ; Badika, Ashish K. ; Mathew, John. / Parvovirus B19 serology in early inflammatory polyarthritis - Experience from a tertiary care teaching hospital in South India. In: Journal of the Indian Medical Association. 2010 ; Vol. 108, No. 10.
@article{d6dfb148427a402ea6fb274121fab300,
title = "Parvovirus B19 serology in early inflammatory polyarthritis - Experience from a tertiary care teaching hospital in South India",
abstract = "This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8{\%}) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.",
keywords = "Early inflammatory arthritis, Parvovirus B19",
author = "D. Danda and Naina, {Harris V K} and Mary Abraham and Mathew, {Ashish Jacob} and Badika, {Ashish K.} and John Mathew",
year = "2010",
month = "10",
language = "English (US)",
volume = "108",
journal = "Journal of the Indian Medical Association",
issn = "0019-5847",
publisher = "Librapharm",
number = "10",

}

TY - JOUR

T1 - Parvovirus B19 serology in early inflammatory polyarthritis - Experience from a tertiary care teaching hospital in South India

AU - Danda, D.

AU - Naina, Harris V K

AU - Abraham, Mary

AU - Mathew, Ashish Jacob

AU - Badika, Ashish K.

AU - Mathew, John

PY - 2010/10

Y1 - 2010/10

N2 - This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8%) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.

AB - This study was done to look for IgM antibody to parvovirus B19 in early inflammatory arthritis patients and their clinical correlations, if any. This was a retrospective case sheet based study and follow-up. IgM antibody to parvovirus B19 was studied in 47 patients who presented to the rheumatology outpatient department with early arthropathy of less than 24 weeks' duration during their first 3 months of onset or flare of arthritis. Seropositive patients were followed up till date. Seven out of the 47 patients had IgM parvo B19 antibody. Five of the 7 had underlying chronic infective, inflammatory and other pre-existing diseases. In 5 patients, the arthritis resolved completely. In the remaining 2, mild recurrent arthralgias were attributed to existing inflammatory diseases. Fever was present in the majority, but none of them had rash. The arthropathy was symmetrical type in the majority. Only 7 (14.8%) out the 47 patients with early inflammatory arthritis had antibody to parvovirus B19, 5 of the 7 had self-limiting course; there was no association of this virus with chronic inflammatory arthropathy in this cohort over a 9-year follow-up.

KW - Early inflammatory arthritis

KW - Parvovirus B19

UR - http://www.scopus.com/inward/record.url?scp=79952419559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952419559&partnerID=8YFLogxK

M3 - Article

VL - 108

JO - Journal of the Indian Medical Association

JF - Journal of the Indian Medical Association

SN - 0019-5847

IS - 10

ER -